Pzena Investment Management LLC lifted its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 2.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,551,065 shares of the technology company's stock after acquiring an additional 132,463 shares during the period. Amdocs makes up approximately 2.0% of Pzena Investment Management LLC's investment portfolio, making the stock its 22nd largest position. Pzena Investment Management LLC owned about 5.80% of Amdocs worth $597,719,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Cornerstone Planning Group LLC acquired a new position in shares of Amdocs in the first quarter valued at about $27,000. Quarry LP grew its stake in shares of Amdocs by 42.2% in the first quarter. Quarry LP now owns 391 shares of the technology company's stock valued at $36,000 after acquiring an additional 116 shares in the last quarter. Cullen Frost Bankers Inc. acquired a new position in shares of Amdocs in the first quarter valued at about $39,000. SVB Wealth LLC acquired a new position in shares of Amdocs in the first quarter valued at about $43,000. Finally, Geneos Wealth Management Inc. grew its stake in Amdocs by 213.9% during the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company's stock worth $64,000 after buying an additional 477 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
DOX has been the topic of a number of analyst reports. Weiss Ratings reiterated a "hold (c+)" rating on shares of Amdocs in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday. Finally, Wolfe Research initiated coverage on shares of Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating on the stock. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $108.00.
Get Our Latest Analysis on Amdocs
Amdocs Stock Down 1.3%
Shares of NASDAQ DOX opened at $80.77 on Monday. The company has a 50 day simple moving average of $84.82 and a 200 day simple moving average of $87.68. The firm has a market cap of $9.12 billion, a PE ratio of 16.38, a price-to-earnings-growth ratio of 1.34 and a beta of 0.51. Amdocs Limited has a 1 year low of $78.61 and a 1 year high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. The business had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.13 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The firm's quarterly revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the business earned $1.62 EPS. On average, research analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is 42.80%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.